Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Sugino

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|August 6, 2021
[Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)]Yusuke Sugino, Kouhei Nishikawa, Momoko Kato, et al.
Translational Cancer Research|February 27, 2024
Postoperative complications and determinant of selecting non intracorporeal urinary diversion in patients undergoing robot-assisted radical cystectomy: an initial experienceTakahiro Inoue, Manabu Kato, Takeshi Sasaki, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate CancerManabu Kato, Shinichiro Higashi, Yusuke Sugino, et al.
Japanese Journal of Clinical Oncology|August 3, 2022
Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study)Takahiro Kojima, Renpei Kato, Tomokazu Sazuka, et al.
Anticancer Research|December 1, 2021
A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell CarcinomaRenpei Kato, Takahiro Kojima, Tomokazu Sazuka, et al.
International Cancer Conference Journal|March 31, 2025
Cisplatin-induced therapy-related myelodysplastic syndrome during avelumab maintenance therapy for metastatic urothelial carcinomaYusuke Sugino, Taketomo Nishikawa, Sota Inaba, et al.
Cancer Science|July 24, 2025
Endothelial-Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate CancerTakumi Kageyama, Manabu Kato, Shiori Miyachi, et al.
International Journal of Clinical Oncology|April 8, 2024
Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancerShunsuke Owa, Takeshi Sasaki, Ryota Ikadai, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2025
[A Case of Paraneoplastic Neurological Syndrome Caused by Bladder Cancer Manifesting as Limbic Encephalitis]Minori Nakatani, Takeshi Sasaki, Chinatsu Sawai, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 3, 2020
[Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma]Taketomo Nishikawa, Yusuke Sugino, Shunsuke Owa, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Hinyokika Kiyo. Acta Urologica Japonica|August 6, 2021
[Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)]Yusuke Sugino, Kouhei Nishikawa, Momoko Kato, et al.
Translational Cancer Research|February 27, 2024
Postoperative complications and determinant of selecting non intracorporeal urinary diversion in patients undergoing robot-assisted radical cystectomy: an initial experienceTakahiro Inoue, Manabu Kato, Takeshi Sasaki, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate CancerManabu Kato, Shinichiro Higashi, Yusuke Sugino, et al.
Japanese Journal of Clinical Oncology|August 3, 2022
Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study)Takahiro Kojima, Renpei Kato, Tomokazu Sazuka, et al.
Anticancer Research|December 1, 2021
A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell CarcinomaRenpei Kato, Takahiro Kojima, Tomokazu Sazuka, et al.
International Cancer Conference Journal|March 31, 2025
Cisplatin-induced therapy-related myelodysplastic syndrome during avelumab maintenance therapy for metastatic urothelial carcinomaYusuke Sugino, Taketomo Nishikawa, Sota Inaba, et al.
Cancer Science|July 24, 2025
Endothelial-Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate CancerTakumi Kageyama, Manabu Kato, Shiori Miyachi, et al.
International Journal of Clinical Oncology|April 8, 2024
Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancerShunsuke Owa, Takeshi Sasaki, Ryota Ikadai, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2025
[A Case of Paraneoplastic Neurological Syndrome Caused by Bladder Cancer Manifesting as Limbic Encephalitis]Minori Nakatani, Takeshi Sasaki, Chinatsu Sawai, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 3, 2020
[Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma]Taketomo Nishikawa, Yusuke Sugino, Shunsuke Owa, et al.
Pageof 4